ScienceDex / Researcher record
Larsen, Glenn
- Aquinnah Pharmaceuticals, Inc. (no department on record)
From the FY2015 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2015
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $499,556 | 1 | #15,621 |
| 2016 | $182,737 | 1 | #32,422 |
| 2018 | $1,303,425 | 2 | #5,280 |
| 2019 | $2,510,981 | 1 | #2,174 |
| 2021 | $1,022,579 | 1 | #8,957 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2015 · selected1 record
- FY20161 record
- FY20182 records
- FY20191 record
- FY20211 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2015 award records by amount
NIH award records listing Larsen, Glenn as a PI. Multi-PI records show the full award amount for context.
- 1R43NS095481-01R43Contact PITDP-43 aggregation inhibitors for the treatment of ALS$499.6Kaward amount
Award organization
Organizations that administered FY2015 awards listing Larsen, Glenn as a PI.
FY2015 award administered by Aquinnah Pharmaceuticals, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardAquinnah Pharmaceuticals, Inc.
- 2016$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #5280
- 2019$2M Cumulative Funding
- 2019Entered Top 25% NationallyRanked #2174
- 2021$5M Cumulative Funding